Cargando…
The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer
BACKGROUND: CX3CL1 is a chemokine that may play important roles in cancer immune regulation. Its mechanism in bladder cancer (BCa) is poorly understood. The objective of the current study was to evaluate the association between CX3CL1 and BCa and the related biological mechanisms. METHODS: A total o...
Autores principales: | Jiang, Guangliang, Wang, Hui, Huang, Da, Wu, Yishuo, Ding, Weihong, Zhou, Qidong, Ding, Qiang, Zhang, Ning, Na, Rong, Xu, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521074/ https://www.ncbi.nlm.nih.gov/pubmed/34671562 http://dx.doi.org/10.3389/fonc.2021.752860 |
Ejemplares similares
-
Chronic Unpredictable Mild Stress Accelerates the Growth of Bladder Cancer in a Xenograft Mouse Model
por: Zhou, Qidong, et al.
Publicado: (2020) -
Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017) -
Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019) -
Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021) -
Penile metastasis secondary to urothelial bladder cancer
por: Dolny, Maciej, et al.
Publicado: (2023)